Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Asston Pharmaceuticals Ltd
Your Vote -
Buy
66.67%
Hold
0.00%
Sell
33.33%
66.67%
3 users have voted
Option Chain
Analyzes market sentiment, predicts Asston Pharmaceuticals Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Asston Pharma - Pursuant To The Provisions Of Regulation 42 Of SEBI (Listing Obligation And Disclosure Requirement) Regulatio
-
Asston Pharma - Board Meeting Outcome for OUTCOME OF THE BOARD MEETING HELD TODAY, I.E., MONDAY, AUGUST 25, 2025
-
Asston Pharma - Board Meeting Intimation for Regulation 29 Of The SEBI (Listing Obligation And Disclosure Requirement) Regula
-
Asston Pharma - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
-
Asston Pharma has submitted to BSE the Shareholding Pattern for the Period Ended July 17, 2025
-
Asston Pharma - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
-
Asston Pharmaceuticals Ltd. debuts with 3.25% discount at Rs 119.00
-
Asston Pharma announces launch of initial public offering
Key fundamentals
Evaluate the intrinsic value of Asston Pharmaceuticals Ltd stock
| Name | March-25 | March-24 | |||
|---|---|---|---|---|---|
| Assets | 17.9749 | 13.2124 | |||
| Liabilities | 17.9749 | 13.2124 | |||
| Equity | 6.2714 | 0.7839 | |||
| Gross Profit | 6.1593 | 2.5458 | |||
| Net Profit | 4.3251 | 1.3603 | |||
| Cash From Operating Activities | -0.1628 | -3.8003 | |||
| NPM(%) | 17.27 | 8.72 | |||
| Revenue | 25.0392 | 15.5862 | |||
| Expenses | 18.8799 | 13.0404 | |||
| ROE(%) | 33.37 | 10.49 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Asston Pharmaceuticals Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 802.00 | 0.50 | 72.66 | 56.62 | 301.39 | 0.62 |
| Lotus Eye Hospital and Institute Ltd | 116.91 | 6.94 | 376.90 | 206.30 | 3.55 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 21.30 | -1.07 | 0.00 | 428.35 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 879.30 | 2.33 | 0.00 | 194.55 | -604.77 | 0.00 |
Company Info
Our Company was originally incorporated as "Asston Pharmaceuticals Private Limited", a private limited company under Companies Act, 2013, pursuant to a certificate of incorporation dated April 16, 2019 issued by Registrar of Companies, Mumbai, Maharashtra. Thereafter, our Company was converted into a public limited company and the name of our Company was changed from "Asston Pharmaceuticals Private Limited" to "Asston Pharmaceuticals Limited" vide fresh certificate of incorporation dated August 29, 2024 issued by the Registrar of Companies, Mumbai, Maharashtra. The Corporate Identification Number of our Company is U24304MH2019PLC324187.MAJOR EVENTS:2019- Incorporation of our Company viz. "Asston Pharmaceuticals Private Limited" under the guidance and leadership of Dr. Ashish Narayan Sakalkar and Mrs. Saili Jayaram More.- Our Company obtained Trade and Export Licenses for 3 major west African Countries namely Sierra Leone, Ghana and Liberia.2020- Our Company obtained registered trademarks in both India and abroad for multiple products,enhancing its images as a pharmaceutical brand in late 2020.2021- Our Company crossed the turnover of 10 cr turnover mark in 2021, less than two years since inception.2022- Established our Manufacturing unit in Mumbai which is one of our Company's achievement making us an independent and reliable supplier.2023- Our Company has successfully ventured into other African countries and is expected to receive registration from Asian markets like Cambodia and Vietnam.2024- Conversion of our Company from Private Limited to Public Limited Company.
Our Company was originally incorporated as "Asston Pharmaceuticals Private Limited", a private limited company under Companies Act, 2013, pursuant to a certificate of incorporation dated April 16, 2019 issued by Registrar of Companies, Mumbai, Maharashtra. Thereafter, our Company was converted into a public limited company and the name of our Company was changed from "Asston Pharmaceuticals Private Limited" to "Asston Pharmaceuticals Limited" vide fresh certificate of incorporation dated August 29, 2024 issued by the Registrar of Companies, Mumbai, Maharashtra. The Corporate Identification Number of our Company is U24304MH2019PLC324187.MAJOR EVENTS:2019- Incorporation of our Company viz. "Asston Pharmaceuticals Private Limited" under the guidance and leadership of Dr. Ashish Narayan Sakalkar and Mrs. Saili Jayaram More.- Our Company obtained Trade and Export Licenses for 3 major west African Countries namely Sierra Leone, Ghana and Liberia.2020- Our Company obtained registered trademarks in both India and abroad for multiple products,enhancing its images as a pharmaceutical brand in late 2020.2021- Our Company crossed the turnover of 10 cr turnover mark in 2021, less than two years since inception.2022- Established our Manufacturing unit in Mumbai which is one of our Company's achievement making us an independent and reliable supplier.2023- Our Company has successfully ventured into other African countries and is expected to receive registration from Asian markets like Cambodia and Vietnam.2024- Conversion of our Company from Private Limited to Public Limited Company.
Read More
Parent Organisation
Asston Pharmaceuticals Ltd.
Founded
16/04/2019
Managing Director
Dr.Ashish Narayan Sakalkar
NSE Symbol
FAQ
The current price of Asston Pharmaceuticals Ltd is
The 52-week high for Asston Pharmaceuticals Ltd is
The market capitalization of Asston Pharmaceuticals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Asston Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Asston Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Asston Pharmaceuticals Ltd shares.
The CEO of Asston Pharmaceuticals Ltd is Dr.Ashish Narayan Sakalkar, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
